AAAAAA
Results: 1-25/51
Authors:
HARTTER S
DINGEMANSE J
BAIER D
ZIEGLER G
HIEMKE C
Citation: S. Hartter et al., INHIBITION OF DEXTROMETHORPHAN METABOLISM BY MOCLOBEMIDE, Psychopharmacology, 135(1), 1998, pp. 22-26
Authors:
HARTTER S
JENSEN B
HIEMKE C
LEAL M
WEIGMANN H
UNGER K
Citation: S. Hartter et al., MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY FOR THERAPEUTIC DRUG-MONITORING OF CARBAMAZEPINE AND ITS MAIN METABOLITES, Journal of chromatography B. Biomedical sciences and applications, 712(1-2), 1998, pp. 253-258
Authors:
WEIGMANN H
HARTTER S
HIEMKE C
Citation: H. Weigmann et al., AUTOMATED-DETERMINATION OF CLOMIPRAMINE AND ITS MAJOR METABOLITES IN HUMAN AND RAT SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE COLUMN-SWITCHING, Journal of chromatography B. Biomedical sciences and applications, 710(1-2), 1998, pp. 227-233
Authors:
VANKAMPEN M
HIEMKE C
FUCHS E
Citation: M. Vankampen et al., PSYCHOSOCIAL STRESS IN TREE SHREWS - DIAZEPAM DOES NOT COUNTERACT STRESS-INDUCED BEHAVIORAL ALTERATIONS, European journal of neuroscience, 10, 1998, pp. 11518-11518
Authors:
GROZINGER M
HARTTER S
HIEMKE C
GRIESE EU
ROSCHKE J
Citation: M. Grozinger et al., INTERACTION OF MODAFINIL AND CLOMIPRAMINE AS COMEDICATION IN A NARCOLEPTIC PATIENT, Clinical neuropharmacology, 21(2), 1998, pp. 127-129
Authors:
FISCHER V
SCHMITT U
WEIGMANN H
VONKELLER B
REUSS S
HIEMKE C
DAHMEN N
Citation: V. Fischer et al., CHRONICAL HALOPERIDOL AND CLOZAPINE TREATMENT IN RATS - DIFFERENTIAL RNA DISPLAY ANALYSIS, BEHAVIORAL-STUDIES AND SERUM LEVEL DETERMINATION, Progress in neuro-psychopharmacology & biological psychiatry, 22(7), 1998, pp. 1129-1139
Authors:
SCHMITT U
HIEMKE C
Citation: U. Schmitt et C. Hiemke, COMBINATION OF OPEN-FIELD AND ELEVATED PLUS-MAZE - A SUITABLE TEST BATTERY TO ASSESS STRAIN AS WELL AS TREATMENT DIFFERENCES IN RAT BEHAVIOR, Progress in neuro-psychopharmacology & biological psychiatry, 22(7), 1998, pp. 1197-1215
Authors:
WETZEL H
ANGHELESCU I
SZEGEDI A
WIESNER J
WEIGMANN H
HARTTER S
HIEMKE C
Citation: H. Wetzel et al., PHARMACOKINETIC INTERACTIONS OF CLOZAPINE WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - DIFFERENTIAL-EFFECTS OF FLUVOXAMINE AND PAROXETINEIN A PROSPECTIVE-STUDY, Journal of clinical psychopharmacology, 18(1), 1998, pp. 2-9
Authors:
HARTTER S
WETZEL H
HAMMES E
TORKZADEH M
HIEMKE C
Citation: S. Hartter et al., SERUM CONCENTRATIONS OF FLUVOXAMINE AND CLINICAL EFFECTS - A PROSPECTIVE OPEN CLINICAL-TRIAL, Pharmacopsychiatry, 31(5), 1998, pp. 199-200
Authors:
SANDMANN J
LORCH B
BANDELOW B
HARTTER S
WINTER P
HIEMKE C
BENKERT O
Citation: J. Sandmann et al., FLUVOXAMINE OR PLACEBO IN THE TREATMENT OF PANIC DISORDER AND RELATIONSHIP TO BLOOD-CONCENTRATIONS OF FLUVOXAMINE, Pharmacopsychiatry, 31(4), 1998, pp. 117-121
Authors:
HARTTER S
WETZEL H
HAMMES E
TORKZADEH M
HIEMKE C
Citation: S. Hartter et al., NONLINEAR PHARMACOKINETICS OF FLUVOXAMINE AND GENDER DIFFERENCES, Therapeutic drug monitoring, 20(4), 1998, pp. 446-449
Authors:
GERMEYER S
BIRKE A
DAHMEN N
HIEMKE C
HAVEMANNREINECKE U
Citation: S. Germeyer et al., INVOLVEMENT OF THE DOPAMINE-RECEPTOR GENES IN INDIVIDUALLY DIFFERENT APOMORPHINE-INDUCED MOTILITY, American journal of medical genetics, 81(6), 1998, pp. 484-484
Authors:
DAHMEN N
FEHR C
SCHLEICHER A
GRUN B
QUERINGS Q
HIEMKE C
Citation: N. Dahmen et al., IDENTIFYING CANDIDATE GENES IN NARCOLEPSY - THE MAINZ FAMILY STUDY, American journal of medical genetics, 81(6), 1998, pp. 521-522
Authors:
SCHMITT U
HIEMKE C
Citation: U. Schmitt et C. Hiemke, STRAIN DIFFERENCES IN OPEN-FIELD AND ELEVATED PLUS-MAZE BEHAVIOR OF RATS WITHOUT AND WITH PRETEST HANDLING, Pharmacology, biochemistry and behavior, 59(4), 1998, pp. 807-811
Authors:
MANN K
WAGNER P
BRUNN G
HASSAN F
HIEMKE C
ROSCHKE J
Citation: K. Mann et al., EFFECTS OF PULSED HIGH-FREQUENCY ELECTROMAGNETIC-FIELDS ON THE NEUROENDOCRINE SYSTEM, Neuroendocrinology, 67(2), 1998, pp. 139-144
Authors:
DEUSCHLE M
HARTTER S
HIEMKE C
STANDHARDT H
HEUSER I
Citation: M. Deuschle et al., DOXEPIN AND ITS METABOLITES IN PLASMA AND CEREBROSPINAL-FLUID IN DEPRESSED-PATIENTS, Psychopharmacology, 131(1), 1997, pp. 19-22
Authors:
KOHLER D
HARTTER S
FUCHS K
SIEGHART W
HIEMKE C
Citation: D. Kohler et al., CYP2D6 GENOTYPE AND PHENOTYPING BY DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN SERUM OF HEALTHY CONTROLS AND OF PATIENTS UNDER PSYCHOTROPIC MEDICATION, Pharmacogenetics, 7(6), 1997, pp. 453-461
Authors:
SCHLOSSER R
SCHLEGEL S
HIEMKE C
NICKEL O
BOCKISCH A
RAO ML
HAHN K
Citation: R. Schlosser et al., [I-123] IBZM SPECT IN PATIENTS TREATED WITH TYPICAL AND ATYPICAL NEUROLEPTICS - RELATIONSHIP TO DRUG PLASMA-LEVELS AND EXTRAPYRAMIDAL SIDE-EFFECTS, PSYCHIATRY RESEARCH-NEUROIMAGING, 75(2), 1997, pp. 103-114
Authors:
BANGER M
HERMES B
HARTTER S
HIEMKE C
Citation: M. Banger et al., MONITORING SERUM CONCENTRATIONS OF CLOMIPRAMINE AND METABOLITES - FLUORESCENCE POLARIZATION IMMUNOASSAY VERSUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Pharmacopsychiatry, 30(4), 1997, pp. 128-132
Authors:
PAULY T
SZEGEDI A
DAHMEN N
BOL GF
FERDINAND K
WETZEL H
HIEMKE C
Citation: T. Pauly et al., BLOOD ETHANOL LEVEL AND ADENYLYL-CYCLASE ACTIVITY IN LYMPHOCYTES OF ACTIVELY DRINKING ALCOHOLICS, European journal of cell biology, 72, 1997, pp. 303-303
Authors:
FEHR C
FICKOVA M
HIEMKE C
REUSS S
DAHMEN N
Citation: C. Fehr et al., MOLECULAR-CLONING OF RAT G-PROTEIN-COUPLED-RECEPTOR-KINASE-6 (GRK6) FROM BRAIN-TISSUE, AND ITS MESSENGER-RNA EXPRESSION IN DIFFERENT BRAIN-REGIONS AND PERIPHERAL-TISSUES, Molecular brain research, 49(1-2), 1997, pp. 278-282
Authors:
WEIGMANN H
BIERBRAUER J
HARTTER S
HIEMKE C
Citation: H. Weigmann et al., AUTOMATED-DETERMINATION OF CLOZAPINE AND MAJOR METABOLITES IN SERUM AND URINE, Therapeutic drug monitoring, 19(4), 1997, pp. 480-488
Authors:
HARTLER S
KOHLER D
FUCHS C
SIEGHART W
HIEMKE C
Citation: S. Hartler et al., EFFECT OF PSYCHOTROPIC MEDICATION ON THE CYTOCHROME P4502D6 PHENOTYPE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 459-459
Authors:
DAHMEN N
FEHR C
REUSS S
HIEMKE C
Citation: N. Dahmen et al., STIMULATION OF IMMEDIATE-EARLY GENE-EXPRESSION BY DESIPRAMINE IN RAT-BRAIN, Biological psychiatry, 42(5), 1997, pp. 317-323
Authors:
SCHLEGEL S
SCHLOSSER R
HIEMKE C
NICKEL O
BOCKISCH A
HAHN K
Citation: S. Schlegel et al., PROLACTIN PLASMA-LEVELS AND D-2-DOPAMINE RECEPTOR OCCUPANCY MEASURED WITH IBZM-SPECT, Psychopharmacology, 124(3), 1996, pp. 285-287